Sodium Citrate Blood-Pack Units, (PL 146 Plastic) (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Sodium Citrate Blood-Pack Units, (PL 146 Plastic) drug offered from Fresenius Kabi USA, LLC. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | Anticoagulant Sodium Citrate Solution |
SUBSTANCE NAME: | TRISODIUM CITRATE DIHYDRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-09-29 |
END MARKETING DATE: | 0000-00-00 |
Sodium Citrate Blood-Pack Units, (PL 146 Plastic) HUMAN PRESCRIPTION DRUG Details:
Item Description | Sodium Citrate Blood-Pack Units, (PL 146 Plastic) from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(g/100mL) |
START MARKETING DATE: | 2014-09-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-505_ccec1a48-d2f4-4130-93d9-d68502321b1d |
PRODUCT NDC: | 63323-505 |
APPLICATION NUMBER: | BN770923 |
Other TRISODIUM CITRATE DIHYDRATE Pharmaceutical Manufacturers / Labelers: